| NDC Code: |
0228-3062 |
| Proprietary Name: |
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate |
| Suffix: |
|
| Non-Proprietary Name: |
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate |
| Dosage Form: |
CAPSULE, EXTENDED RELEASE |
| Method: |
ORAL |
| Original Marketing Date: |
10-12-2012 |
| Category Name: |
ANDA |
| Application Number: |
ANDA077302 |
| Labeler: |
ACTAVIS ELIZABETH LLC |
| Substance Name: |
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE |
| Active Numerator Strength: |
1.25; 1.25; 1.25; 1.25 |
| Active Ingredient Unit: |
mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes: |
Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
| DEA Schedule: |
CII |
